化合物GGTI 298 T6844
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mg | 1217457-86-7 | ¥747.00 | 询底价 |
10 mg | 1217457-86-7 | ¥2,320.00 | 询底价 |
5 mg | 1217457-86-7 | ¥1,490.00 | 询底价 |
25 mg | 1217457-86-7 | ¥4,570.00 | 询底价 |
1 mL | 1217457-86-7 | ¥1,950.00 | 询底价 |
50 mg | 1217457-86-7 | ¥6,230.00 | 询底价 |
Product Introduction
Bioactivity
英文名: GGTI298 Trifluoroacetate
描述: GGTI298 Trifluoroacetate (GGTI 298 TFA salt) 是一种GGTase I 抑制剂,能够抑制Rap1A 且IC50值为3μM,对Ha-Ras 的作用很小IC50值 > 20 μM。
细胞实验: Cells were treated with GGTI-298 (15 μM) for 48 h, harvested, and lysed in HEPES lysis buffer. Proteins were then resolved by 12.5% or 7% SDS-PAGE gel and immunoblotted with antibodies. The ECL blotting system was used for detection of positive antibody reactions.(Only for Reference)
体外活性: The geranylgeranyltransferase I inhibitor GGTI-298 has been shown to arrest human tumor cells in the G1 phase of the cell cycle and induce apoptosis. Treatment of the human lung carcinoma cell line Calu-1 with GGTI-298 results in inhibition of the phosphorylation of retinoblastoma protein, a critical step for G1/S transition. The kinase activities of two G1/S cyclin-dependent kinases, CDK2 and CDK4, are inhibited in Calu-1 cells treated with GGTI-298. GGTI-298 has little effect on the expression levels of CDK2, CDK4, CDK6, cyclins D1 and E, but decreases the levels of cyclin A. GGTI-298 increases the levels of the cyclin-dependent kinase inhibitors p21 and p15 and had little effect on those of p27 and p16. GGTI-298 promotes binding of p21 and p27 to CDK2 while decreasing their binding to CDK6. Its treatment results in an increased binding of p15 to CDK4, which is paralleled with decreased binding to p27. Pretreatment of fibroblasts with GGTI-298, blocks PDGF- and epidermal growth factor-dependent tyrosine phosphorylation of their corresponding tyrosine kinase receptors. GGTI-298 has antiproliferative effects on fibroblasts, epithelial, and smooth muscle cells, and this cell growth inhibition appears to be mediated through a G1 phase arrest[1].
体内活性: GGTI-298 inhibits tumor growth in nude mice[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 14.8 mg/mL (25 mM)
关键字: Apoptosis | GGTI 298 TFA | inhibit | GGTI298 | GGTI 298 Trifluoroacetate | GGTI-298 Trifluoroacetate | Inhibitor | GGTI298 Trifluoroacetate | Ras | GGTI-298
相关产品: Apoptosis inducer 11 | Lidocaine hydrochloride | GSK1904529A | Mezigdomide | Nortriptyline hydrochloride | Lexibulin | Hypericin | ZM-447439 | Fimepinostat | WYC-209
相关库: Glutamine Metabolism Compound Library | Fluorochemical Library | Reprogramming Compound Library
化合物GGTI 298 T6844信息由TargetMol中国为您提供,如您想了解更多关于化合物GGTI 298 T6844报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途